Financial

HuidaGene Therapeutics Appoints TJ Cradick, PhD as Chief Technology Officer to Lead Delivery Science and Genome Editing Innovations

SHANGHAI and MIDDLETOWN, Del., Oct. 21, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines,...

Exploratory Mindset Drives Insights at HLTH 2024: Black Book Poll Reveals Attendees Prioritizing Learning Over Immediate Investments

Survey reveals attendees are postponing AI and IT initiatives as budget constraints shift focus to internal system challenges, with unproven...

Evvy Announces the Company’s First Chief Medical Officer and Publishes Peer-Reviewed Validation on the Evvy Vaginal Health Test, Advancing its Mission of Unlocking Precision Female Healthcare

Telerehabilitation Systems Market to Expand by USD 532.9 Million (2024-2028), Driven by Chronic Disease Rise and AI Influence – Technavio

NEW YORK, Oct. 16, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global telerehabilitation systems market size is...

89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024

SAN FRANCISCO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...

error: Content is protected !!